Drug Profile
Interferon alpha-2b biosimilar - Laboratorio Varifarma
Alternative Names: Interferon alfa 2b Cassara; Interferón alfa 2b recombinante humanoLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Laboratorio Varifarma
- Developer Laboratorio Pablo Cassara; Laboratorio Varifarma
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer; Condylomata acuminata; Hepatitis B; Hepatitis C
Most Recent Events
- 04 Mar 2014 Launched prior to this date for Cancer in Argentina (Parenteral)
- 04 Mar 2014 Launched prior to this date for Condylomata acuminata in Argentina (Intralesional)
- 04 Mar 2014 Launched prior to this date for Hepatitis B in Argentina (Parenteral)